Contact Us: 01282 426380
KM Financial Solutions | U.S. FDA chief questions protections on drug rebates, stocks fall
16267
post-template-default,single,single-post,postid-16267,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

U.S. FDA chief questions protections on drug rebates, stocks fall

02 May U.S. FDA chief questions protections on drug rebates, stocks fall

Posted at 20:45h in News by
0 Likes
May 3 (Reuters) – U.S. Food and Drug Administration chief
Scott Gottlieb on Thursday questioned whether rebates that
drugmakers provide to health insurers should remain protected by
federal law, sparking new concerns on Wall Street over efforts
to curb drug pricing.

No Comments

Sorry, the comment form is closed at this time.